Vitality Watch

Dossier pubmed preclinical 20-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Modulating Ubiquinone Biosynthesis Rescues Mitochondrial Dysfunction by Genetic Interaction in a Phosphatidylethanolamine (PE)-Deficient Disease Model.

Key claim: In a C. elegans PE-deficient (PSD-1 knockdown) disease model, co-modulating ubiquinone biosynthesis/ETC function rescues shortened lifespan, oxygen consumption, and other mitochondrial defects, implicating ETC-mediated retrograde signaling over phospholipid loss alone.

Abstract

Mitochondrial dysfunctions are often associated with cellular aging as well as metabolic disorders. Therapeutic strategies for rewiring mitochondrial stress signaling in a disease context could be beneficial. New evidence indicates that mitochondrial membrane lipids actively regulate mitochondrial signaling pathways that influence cellular health, stress responses, and longevity. Phosphatidylethanolamine (PE), the non-bilayer-forming phospholipid, plays major roles in mitochondrial morphology and ETC function. The biosynthesis of PE takes place within the inner mitochondrial membrane and is catalyzed by the enzyme phosphatidylserine decarboxylase-1 (PSD-1), which converts phosphatidylserine (PS) to PE. While the biochemical role of PSD-1 in PE biosynthesis is well established, how its dysfunction translates into mitochondrial pathology remains poorly understood. In this work, we describe the physiological implications of PSD-1 function and validate a novel disease model for human(the ortholog of.) by undertaking targeted gene knockdown using RNA interference (RNAi) in. We show thatdeficiency causes several physiological defects in, demonstrating that PE biosynthesis via PSD-1 is critical for mitochondrial activity and organismal development (mitochondrial PE levels were reduced by 69.51% inknockdown worms compared to controls). These findings establishknockdown worms as a reliable model for studying human-related disease. Surprisingly, co-knockdown ofalong with the ETC componentrescued physiological defects such as restoring the lifespan of from 13.48 ± 0.51 daysRNAi worms to 17.36 ± 0.44 days in;double-knockdown worms and normalizing oxygen consumption rate, suggesting that ETC-mediated retrograde signaling, rather than phospholipid depletion alone, is the primary driver of the observed pathology.

Why this matters

The result reassigns the proximal lesion in a PE-deficiency mitochondrial disease model from bulk phospholipid depletion to ETC dysfunction and its retrograde signaling — a mechanistic reframing that matters for how aging biologists interpret any intervention (dietary PE precursors, CoQ analogs, ETC modulators) aimed at membrane-lipid or bioenergetic defects. It also validates a tractable C. elegans genetic-interaction platform for dissecting phospholipid–ETC crosstalk, though the translation gap from worm rescue to human mitochondrial disease or aging remains wide.

Source

Link

Briefing card

Modulating Ubiquinone Biosynthesis Rescues Mitochondrial Dysfunction by Genetic Interaction in a Phosphatidylethanolamine (PE)-Deficient Disease Model.
Stage: preclinical · pubmed · 20-sep-2026

If you take CoQ10 expecting mitochondrial benefit, this is a worm genetic-rescue study clarifying mechanism — not new human outcome evidence.

In a C. elegans PE-deficient (PSD-1 knockdown) disease model, co-modulating ubiquinone biosynthesis/ETC function rescues shortened lifespan, oxygen consumption, and other mitochondrial defects, implicating ETC-mediated retrograde signaling over phospholipid loss alone.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3390/antiox15091212

build build 880 · 2bcef25 · 2026-11-18